Alerus Financial’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Buy
13,956
+13,867
+15,581% +$1.07M 0.05% 148
2025
Q4
$7.06K Hold
89
﹤0.01% 382
2025
Q3
$6.71K Hold
89
﹤0.01% 415
2025
Q2
$6.14K Buy
+89
New +$5.84K ﹤0.01% 398
2023
Q3
Sell
-66,225
Closed -$4.58M 155
2023
Q2
$4.58M Buy
66,225
+3,455
+6% +$246K 0.39% 73
2023
Q1
$4.66M Buy
62,770
+2,005
+3% +$168K 0.41% 71
2022
Q4
$5.66M Buy
60,765
+7,631
+14% +$736K 0.52% 61
2022
Q3
$5.07M Buy
53,134
+18,193
+52% +$1.8M 0.5% 57
2022
Q2
$3.24M Sell
34,941
-432
-1% -$42.2K 0.3% 76
2022
Q1
$3.58M Sell
35,373
-253
-0.7% -$26.6K 0.31% 86
2021
Q4
$3.67M Sell
35,626
-7,835
-18% -$724K 0.3% 86
2021
Q3
$3.69M Sell
43,461
-77
-0.2% -$6.45K 0.34% 78
2021
Q2
$3.63M Sell
43,538
-4,248
-9% -$348K 0.37% 74
2021
Q1
$3.6M Sell
47,786
-1,516
-3% -$110K 0.38% 73
2020
Q4
$3.37M Buy
49,302
+1,296
+3% +$84.3K 0.34% 80
2020
Q3
$2.8M Sell
48,006
-12,218
-20% -$760K 0.32% 80
2020
Q2
$3.91M Buy
60,224
+8,936
+17% +$563K 0.46% 62
2020
Q1
$3.04M Buy
51,288
+18,973
+59% +$1.27M 0.42% 68
2019
Q4
$2.4M Buy
32,315
+27,576
+582% +$1.94M 0.27% 85
2019
Q3
$299K Sell
4,739
-450
-9% -$26.7K 0.04% 133
2019
Q2
$283K Sell
5,189
-48,752
-90% -$2.63M 0.04% 134
2019
Q1
$2.91M Buy
53,941
+23,214
+76% +$1.43M 0.41% 66
2018
Q4
$2.01M Sell
30,727
-1,291
-4% -$96.4K 0.31% 81
2018
Q3
$2.52M Sell
32,018
-908
-3% -$64.9K 0.34% 78
2018
Q2
$2.12M Buy
32,926
+1,101
+3% +$72.6K 0.3% 84
2018
Q1
$1.98M Buy
31,825
+27,248
+595% +$1.96M 0.28% 88
2017
Q4
$332K Sell
4,577
-75,438
-94% -$5.48M 0.05% 119
2017
Q3
$6.51M Buy
80,015
+1,267
+2% +$100K 0.95% 33
2017
Q2
$6.34M Sell
78,748
-23
-0% -$1.82K 0.94% 30
2017
Q1
$6.18M Buy
78,771
+908
+1% +$72.5K 0.95% 33
2016
Q4
$6.14M Buy
77,863
+6,508
+9% +$527K 0.99% 28
2016
Q3
$6.35M Sell
71,355
-743
-1% -$70.1K 1.03% 29
2016
Q2
$6.9M Buy
+72,098
New +$7.19M 1.15% 24

Other funds holding CVS

Alerus Financial's CVS Position: Q1 2026 in Review

Alerus Financial increased its CVS Health (CVS) stake by 15,581% in Q1 2026, buying an estimated $1.07M and bringing the position to 13,956 shares worth $1M. The position accounts for 0.05% of the portfolio, ranked #148.

Alerus Financial first reported a position in CVS in Q2 2016 and has held it in 33 quarters since. The position peaked at $6.9M in Q2 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Alerus Financial held 13,956 shares of CVS Health worth $1M as of Q1 2026.
  • Alerus Financial bought 13,867 CVS Health shares in Q1 2026, an estimated $1.07M.
  • CVS Health made up 0.05% of Alerus Financial's portfolio in Q1 2026, its #148 holding.
  • Alerus Financial first reported a position in CVS Health in Q2 2016 and has held it in 33 quarters since.
  • Alerus Financial's CVS Health position peaked at $6.9M in Q2 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.